Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-infected patients in Thailand

Published:2023-10-25 Issue:1 Volume:26 Page:1330-1341
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Kategeaw Warittakorn¹^ORCID,Nakkam Nontaya²^ORCID,Kiertiburanakul Sasisopin³^ORCID,Sukasem Chonlaphat⁴⁵⁶^ORCID,Tassaneeyakul Wichittra²^ORCID,Chaiyakunapruk Nathorn¹⁷^ORCID

Affiliation:

1. Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA

2. Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

3. Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

4. Division of Pharmacogenomics and Personalized Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

5. Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand

6. The Thai Severe Cutaneous Adverse Drug Reaction (THAI-SCAR) Research Group, Bangkok, Thailand

7. IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA

Funder

Health System Research Institute under Genomics Thailand Strategic Fund

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2270868

Reference61 articles.

1. Severe Adverse Cutaneous Reactions to Drugs

2. Recent advances in the understanding of severe cutaneous adverse reactions

3. Treatments for Severe Cutaneous Adverse Reactions

4. Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis

5. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual approaches in pharmacogenetics: Developing PCR-SSP and RT-PCR methods for HLA-B*13:01 screening to prevent dapsone and Co-trimoxazole SCARs;Heliyon;2024-08

2. HLA-B*13:01 screening not cost effective prior to cotrimoxazole use;Reactions Weekly;2023-10-21